Search results for "Myocardial infarction"
New trials provide data to improve medication management in hypertension
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
https://immattersacp.org/weekly/archives/2022/10/18/6.htm
18 Oct 2022
Studies of LDL levels, therapies support treatment of those older than age 70
A retrospective study found the association between low-density lipoprotein (LDL) cholesterol levels and cardiovascular events to increase with age, while a meta-analysis highlighted the benefits of statins and other lipid-lowering therapies in older patients.
https://immattersacp.org/weekly/archives/2020/11/17/4.htm
17 Nov 2020
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
Patients may respond differently to different hypertension drug classes
The authors of a randomized, double-blind, repeated crossover trial in Sweden estimated that personalized antihypertensive therapy could yield an average reduction in systolic blood pressure of 4.4 mm Hg compared to fixed-choice therapy.
https://immattersacp.org/weekly/archives/2023/04/18/1.htm
18 Apr 2023
ARBs appear to have fewer side effects, same effectiveness compared to ACE inhibitors
Researchers used large international databases to compare outcomes among patients who initiated hypertension therapy with angiotensin-converting enzyme (ACE) inhibitors versus angiotensin receptor blockers (ARBs) and concluded that ARBs should be preferred.
https://immattersacp.org/weekly/archives/2021/08/03/2.htm
3 Aug 2021
NSAIDs associated with increased risk of bleeding, cardiovascular events after MI
Compared to other NSAIDs, celecoxib and meloxicam were associated with a lower risk of bleeding or cardiovascular events among Korean patients who had a myocardial infarction (MI).
https://immattersacp.org/weekly/archives/2020/07/28/5.htm
28 Jul 2020
MKSAP Quiz: Treatment of elevated cholesterol levels
A 58-year-old man is evaluated during a routine visit. He has psoriatic arthritis and hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2021/12/14/3.htm
14 Dec 2021
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
https://immattersacp.org/weekly/archives/2021/10/19/2.htm
19 Oct 2021
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Ophthalmic procedures do not increase heart attack risk, study finds
The Scandinavian study supports recommendations that for average-risk patients undergoing most types of outpatient eye surgery, preoperative cardiac tests are unnecessary.
https://immattersacp.org/weekly/archives/2022/03/22/1.htm
22 Mar 2022